UK – NHS patients to be given experimental coronavirus therapy remdesivir

The government has announced that certain NHS patients with coronavirus will soon be able to access Gilead’s remdesivir in a bid to speed up their recovery.

The drug is currently being tested in clinical trials around the world, with early data showing it can shorten the time to recovery by about four days.

The Early Access to Medicines Scheme (EAMS) and scientific opinion from the Medicines and Healthcare products Regulatory Agency (MHRA) supports NHS use of remdesivir where it is likely to deliver the greatest benefit.